Applied Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Applied Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2018 to Q3 2024.
  • Applied Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.09M, a 13.9% increase year-over-year.
  • Applied Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $7.99M, a 2.29% decline year-over-year.
  • Applied Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.36M, a 23.4% decline from 2022.
  • Applied Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.6M, a 14.1% decline from 2021.
  • Applied Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.2M, a 39.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $7.99M $2.09M +$255K +13.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $7.73M $1.89M +$47K +2.55% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $7.68M $2.38M +$324K +15.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $7.36M $1.63M -$813K -33.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $8.17M $1.84M -$1.02M -35.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $9.19M $1.84M -$388K -17.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $9.58M $2.06M -$22K -1.06% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $9.6M $2.44M -$410K -14.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $10M $2.86M +$211K +7.98% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $9.8M $2.23M -$471K -17.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $10.3M $2.08M -$904K -30.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $11.2M $2.85M +$130K +4.78% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $11M $2.65M +$242K +10.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $10.8M $2.7M +$1.13M +71.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $9.68M $2.98M +$1.65M +124% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $8.03M $2.72M +$1.37M +102% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $6.66M $2.4M +$1.18M +97% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $5.47M $1.57M -$1.71M -52% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $7.18M $1.33M +$1.01M +310% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $6.17M $1.35M +$1.26M +1365% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 $4.92M $1.22M +$1.14M +1464% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $3.77M $3.28M +$3.2M +4213% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $571K $325K +$299K +1150% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $272K $92K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 $78K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $76K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $26K Jan 1, 2018 Mar 31, 2018 10-Q 2019-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.